Austar Lifesciences Limited
AULSF
$0.02
-$0.05-71.43%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 10.27% | 8.69% | -5.43% | -6.79% | -4.95% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 10.27% | 8.69% | -5.43% | -6.79% | -4.95% |
| Cost of Revenue | 12.66% | 11.04% | -5.76% | -7.11% | -7.06% |
| Gross Profit | 0.39% | -1.05% | -4.17% | -5.56% | 4.87% |
| SG&A Expenses | -10.25% | -11.53% | -1.67% | -3.09% | -18.53% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 44.23% | 45.04% | 17.90% | 19.08% | -207.54% |
| Total Operating Expenses | 9.47% | 7.90% | -5.71% | -7.07% | -9.83% |
| Operating Income | 52.34% | 50.15% | 4.34% | 2.84% | 151.72% |
| Income Before Tax | 50.89% | 48.74% | 230.35% | 225.59% | 142.94% |
| Income Tax Expenses | 233.61% | 228.82% | 34.06% | 32.13% | 267.50% |
| Earnings from Continuing Operations | 0.21% | -1.22% | 464.59% | 456.50% | 135.60% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -156.94% | -156.12% | -17.84% | -19.05% | -33.06% |
| Net Income | -12.41% | -13.66% | 325.97% | 319.86% | 113.93% |
| EBIT | 52.34% | 50.15% | 4.34% | 2.84% | 151.72% |
| EBITDA | 22.22% | 20.47% | 4.82% | 3.31% | 307.00% |
| EPS Basic | -14.29% | -14.29% | 325.00% | 325.00% | 114.14% |
| Normalized Basic EPS | 114.29% | 114.29% | 150.00% | 150.00% | 126.92% |
| EPS Diluted | -21.43% | -21.43% | 385.71% | 385.71% | 114.14% |
| Normalized Diluted EPS | 114.29% | 114.29% | 150.00% | 150.00% | 126.92% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |